| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $205.1M | +12.7% | +77.1% |
| Cost of Revenue | $70.6M | +11.4% | +125.3% |
| Gross Profit | $134.5M | +13.5% | +59.2% |
| R&D Expense | $52.1M | +4.6% | +42.2% |
| SG&A Expense | $31.4M | -28.9% | +38.7% |
| Operating Income | $6.6M | +145.0% | -10.7% |
| Pre-tax Income | -$10.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $60.8M | -11.2% | -73.4% |
| Short-term Investments | $3.4M | -3.4% | -95.6% |
| Accounts Receivable | $152.8M | +3.2% | +52.2% |
| Current Assets | $250.8M | -2.6% | -41.8% |
| Total Assets | $2.99B | -1.0% | +379.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $120.6M | — | — |
| Capital Expenditures | $8.5M | — | — |
| Investing Cash Flow | -$988.5M | — | — |
| Financing Cash Flow | $750.2M | — | — |
| Free Cash Flow | $112.1M | — | — |
| +62.2% |
| -333.6% |
| Income Tax | $510K | +121.7% | +204.9% |
| Net Income | -$10.3M | +55.5% | -384.8% |
| EPS (Basic) | -$0.04 | +55.6% | -300.0% |
| EPS (Diluted) | -$0.04 | +55.6% | -300.0% |
| $127.6M |
| -0.0% |
| +38.1% |
| Long-term Debt | $838.9M | -4.5% | — |
| Total Liabilities | $989.0M | -4.3% | +482.3% |
| Stockholders' Equity | $1.98B | +0.7% | +391.4% |